# FDA recall D-0417-2015

> **Hospira Inc.** · Class II · drug recall initiated 2015-03-05.

## Product

5% DEXTROSE Injection, USP, 250 mL ADD-Vantage Unit bag (NDC 0409-7100-02), UPC (01)0030404097100026; packaged in 24 bags per case pack (NDC 0409-7100-02), UPC (01)30304097100027(30)01, Rx ONLY, Hospira, Inc., Lake Forest, IL 60045.

## Reason for recall

Lack of Assurance of Sterility: there is a potential for solution to leak at the administrative port of the primary container.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-0417-2015
- **Recalling firm:** Hospira Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2015-03-05
- **Report date:** 2015-03-25
- **Termination date:** 2016-12-09

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lake Forest, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0417-2015

## Citation

> AI Analytics. FDA recall D-0417-2015. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0417-2015. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*